[HTML][HTML] Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
ML Shiffman, F Suter, BR Bacon… - … England Journal of …, 2007 - Mass Medical Soc
Background Patients infected with hepatitis C virus (HCV) genotype 2 or 3 have sustained
virologic response rates of approximately 80% after receiving treatment with peginterferon …
virologic response rates of approximately 80% after receiving treatment with peginterferon …
Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised …
JV Madruga, D Berger, M McMurchie, F Suter… - The Lancet, 2007 - thelancet.com
Background The protease inhibitor darunavir has been shown to be efficacious in highly
treatment-experienced patients with HIV infection, but needs to be assessed in patients with a …
treatment-experienced patients with HIV infection, but needs to be assessed in patients with a …
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study …
…, GE Peterson, E Rubinstein, DJ Sexton, F Suter… - American heart …, 2007 - Elsevier
BACKGROUND: Embolic events to the central nervous system are a major cause of morbidity
and mortality in patients with infective endocarditis (IE). The appropriate role of valvular …
and mortality in patients with infective endocarditis (IE). The appropriate role of valvular …
Health care–associated native valve endocarditis: importance of non-nosocomial acquisition
…, AS Kumar, FM Nacinovich, F Suter… - Annals of internal …, 2009 - acpjournals.org
Background: The clinical profile and outcome of nosocomial and non-nosocomial health
care–associated native valve endocarditis are not well defined. Objective: To compare the …
care–associated native valve endocarditis are not well defined. Objective: To compare the …
Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors
…, G Quinzan, C Arici, M Airoldi, F Suter - Clinical infectious …, 2005 - academic.oup.com
Background . This prospective study verified the effect of adherence on the risk of virologic
failure. Methods . At enrollment in the study, a total of 543 patients who were following a …
failure. Methods . At enrollment in the study, a total of 543 patients who were following a …
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects
…, G Orofino, L Sighinolfi, A Gori, F Suter… - Patient preference …, 2010 - Taylor & Francis
Objective: The aim of the ADONE (ADherence to ONE pill) study was to verify the effect of a
reduced number of pills on adherence and quality of life (QoL) in HIV-infected patients on …
reduced number of pills on adherence and quality of life (QoL) in HIV-infected patients on …
Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis
…, MB Pasticci, P Grossi, R Utili, P Viale, M Rizzi, F Suter - Infection, 2012 - Springer
Background The characteristics of patients with infective endocarditis (IE) vary significantly
by region of the world. The aim of this study was to evaluate the contemporary epidemiology, …
by region of the world. The aim of this study was to evaluate the contemporary epidemiology, …
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
N Perico, M Cortinovis, F Suter… - The Lancet Infectious …, 2023 - thelancet.com
COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of symptom
severity that requires varying amounts of care according to the different stages of the disease. …
severity that requires varying amounts of care according to the different stages of the disease. …
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C
E Minola, D Prati, F Suter, F Maggiolo… - Blood, The Journal …, 2002 - ashpublications.org
Before the introduction of hepatitis C virus (HCV) screening for blood donors, the risk of
acquiring HCV infection as a result of a transfusion was about 10%. The aim of this study was to …
acquiring HCV infection as a result of a transfusion was about 10%. The aim of this study was to …
Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients
…, V Ravasio, C Arici, E Bombana, F Suter - HIV clinical …, 2007 - Taylor & Francis
Background: The effect of adherence on the risk of virologic failure and mutations selection
was verified in a prospective study. Method: At baseline, all patients had a viral load (VL) <50 …
was verified in a prospective study. Method: At baseline, all patients had a viral load (VL) <50 …
